|
|
|
LifeScienceHistory.com - Check us out on Instagram
Massachusetts Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing MassachusettsLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Anchor Therapeutics
| | | Phone: | (617) 715-1999 | Fax: | (617) 715-7906 | Year Established: | 2002 | Main Contact: | Frederick Jones, M.D., M.B.A., President & CEO | | Other Contacts: | Thomas McMurry, Ph.D., VP, Preclinical R&D Stephen Hunt, Ph.D., Senior VP, Discovery Research
| | Company Description | Anchor Therapeutics, formerly Ascent Therapeutics, designs and develops peptide modulators of G protein-coupled receptors (GPCRs), the largest family of drug targets. Anchor’s peptides, called pepducins, modulate GPCR activity utilizing a unique intracellular allosteric mechanism that is well suited for a wide variety of targets, including intractable and orphan receptors. Anchor and its pharma collaborators are leveraging the broad applications of pepducin technology to create new treatment options for regenerative medicine, diabetes, inflammation and cancer. | |
|
|
|
|
|